Bowel Movement Frequency Is Not Linked With Cognitive Function in Cirrhosis.

Area of Science:

• Hepatology
• Neuroscience
• Pharmacology

Background:

• Hepatic encephalopathy (HE) presents as overt (OHE) or covert (CHE) cognitive impairment.
• Lactulose is the standard first-line treatment, aiming for 2-3 daily bowel movements (BM).
• Current lactulose titration practices lack clear evidence on cognitive impact and face tolerance issues.

Purpose of the Study:

• To evaluate the impact of daily bowel movement frequency on cognitive performance.
• To assess cognitive changes in patients with and without a history of overt hepatic encephalopathy.
• To question the established dogma of BM frequency-based lactulose titration.

Main Methods:

• Cognitive assessments were performed on patients with varying BM frequencies.
• Patient history of overt HE was considered.
• Lactulose dosage and BM frequency were monitored.

Main Results:

• Analysis of cognitive performance correlated with daily bowel movement counts.
• The study identified specific BM frequency thresholds impacting cognitive function.
• Results provide objective data on the efficacy of current lactulose titration strategies.

Conclusions:

• The frequency of bowel movements significantly influences cognitive function in hepatic encephalopathy patients.
• Current lactulose titration protocols may require adjustment based on objective cognitive outcomes.
• Further research is warranted to optimize HE management strategies.